HK1114840A1 - Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease - Google Patents
Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's diseaseInfo
- Publication number
- HK1114840A1 HK1114840A1 HK08104728.3A HK08104728A HK1114840A1 HK 1114840 A1 HK1114840 A1 HK 1114840A1 HK 08104728 A HK08104728 A HK 08104728A HK 1114840 A1 HK1114840 A1 HK 1114840A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- secretase
- alzheimer
- gamma
- inhibitors
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04106395 | 2004-12-08 | ||
EP05100816 | 2005-02-07 | ||
PCT/EP2005/012834 WO2006061136A2 (fr) | 2004-12-08 | 2005-12-01 | Dérivés de malonamide |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1114840A1 true HK1114840A1 (en) | 2008-11-14 |
Family
ID=36293585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08104728.3A HK1114840A1 (en) | 2004-12-08 | 2008-04-29 | Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease |
Country Status (23)
Country | Link |
---|---|
US (1) | US7211573B2 (fr) |
EP (1) | EP1828151B1 (fr) |
JP (1) | JP4979590B2 (fr) |
KR (1) | KR100890678B1 (fr) |
CN (1) | CN101072760B (fr) |
AR (1) | AR053987A1 (fr) |
AT (1) | ATE504580T1 (fr) |
AU (1) | AU2005313582B8 (fr) |
BR (1) | BRPI0518615A2 (fr) |
CA (1) | CA2589196A1 (fr) |
DE (1) | DE602005027388D1 (fr) |
DK (1) | DK1828151T3 (fr) |
HK (1) | HK1114840A1 (fr) |
IL (1) | IL183293A0 (fr) |
MX (1) | MX2007006504A (fr) |
NO (1) | NO20072609L (fr) |
NZ (1) | NZ555184A (fr) |
PL (1) | PL1828151T3 (fr) |
PT (1) | PT1828151E (fr) |
RU (1) | RU2402538C2 (fr) |
TW (1) | TWI349005B (fr) |
WO (1) | WO2006061136A2 (fr) |
ZA (1) | ZA200705018B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101096476B1 (ko) | 2006-09-20 | 2011-12-20 | 에프. 호프만-라 로슈 아게 | 4-옥소-2,3,4,5-테트라히드로-벤조[b][1,4]디아제핀 유도체 |
EP2109604A1 (fr) * | 2007-02-02 | 2009-10-21 | F. Hoffmann-Roche AG | Dérivés 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azépin-7-yliques |
EP2244713A1 (fr) * | 2008-01-11 | 2010-11-03 | F. Hoffmann-La Roche AG | Utilisation d'un inhibiteur de la gamma-sécrétase pour le traitement du cancer |
US8741889B2 (en) * | 2008-01-11 | 2014-06-03 | Hoffmann-La Roche Inc | Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor |
JP6877365B2 (ja) | 2015-06-11 | 2021-05-26 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 標的化されたNotch経路阻害剤 |
CA3079786A1 (fr) | 2017-10-24 | 2019-05-02 | The Broad Institute, Inc. | Derives de 4h-pyrrolo[3,2-c]pyridin-4-one |
US20220017456A1 (en) * | 2018-11-07 | 2022-01-20 | Chugai Seiyaku Kabushiki Kaisha | O-substituted serine derivative production method |
TW202106683A (zh) | 2019-04-24 | 2021-02-16 | 德商拜耳廠股份有限公司 | 4H-吡咯并[3,2-c]吡啶-4-酮化合物 |
WO2020216773A1 (fr) | 2019-04-24 | 2020-10-29 | Bayer Aktiengesellschaft | Composés de 4h-pyrrolo[3,2-c]pyridin-4-one |
CA3137611A1 (fr) | 2019-04-24 | 2020-10-29 | Bayer Aktiengesellschaft | Derives de 4h-pyrrolo[3,2-c]pyridin-4-one |
CN112300019A (zh) * | 2019-07-31 | 2021-02-02 | 华东师范大学 | 一种邻乙酰氨基苯丁酸类化合物的制备方法 |
CA3177214A1 (fr) | 2020-03-31 | 2021-10-07 | Bayer Aktiengesellschaft | Derives de 3-(anilino)-2-[3-(3-alcoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo [3,2-c] pyridin-4-one en tant qu'inhibiteurs d'egfr pour le traitement du cancer |
KR20230155446A (ko) | 2021-03-09 | 2023-11-10 | 바스프 에스이 | 말론아미드 및 제초제로서의 그의 용도 |
AR126867A1 (es) * | 2021-08-25 | 2023-11-22 | Basf Se | Malonamidas herbicidas |
AU2022339008A1 (en) * | 2021-08-31 | 2024-03-14 | Basf Se | Herbicidal malonamides containing a condensed ring system |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
WO1999067219A1 (fr) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Composes destines a inhiber la liberation et/ou la synthese du peptide beta-amyloide |
GB0012671D0 (en) | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
ATE430726T1 (de) * | 2002-05-29 | 2009-05-15 | Hoffmann La Roche | N-acylamino-benzyletherderivate als selektive inhibitoren der monoaminoxidase b |
TW200502221A (en) * | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
EP1592684B1 (fr) | 2003-02-04 | 2008-07-30 | F. Hoffmann-La Roche Ag | Derives de malonamide utilises comme inhibiteurs de la gamma-secretase |
US7060698B2 (en) | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
PT1711470E (pt) | 2003-09-09 | 2009-05-21 | Hoffmann La Roche | Derivados de malonamida que bloqueiam a actividade de gama-secretase |
MXPA06003870A (es) | 2003-10-06 | 2006-07-03 | Hoffmann La Roche | Derivados de dibenzo-azepina y benzo-diazepina substituidas utiles como inhibidores de gama-secretasa. |
-
2005
- 2005-11-30 US US11/289,176 patent/US7211573B2/en not_active Expired - Fee Related
- 2005-12-01 CA CA002589196A patent/CA2589196A1/fr not_active Abandoned
- 2005-12-01 KR KR1020077015604A patent/KR100890678B1/ko not_active IP Right Cessation
- 2005-12-01 AU AU2005313582A patent/AU2005313582B8/en not_active Ceased
- 2005-12-01 CN CN2005800421635A patent/CN101072760B/zh not_active Expired - Fee Related
- 2005-12-01 BR BRPI0518615-3A patent/BRPI0518615A2/pt not_active IP Right Cessation
- 2005-12-01 WO PCT/EP2005/012834 patent/WO2006061136A2/fr active Application Filing
- 2005-12-01 DK DK05811672.4T patent/DK1828151T3/da active
- 2005-12-01 JP JP2007544779A patent/JP4979590B2/ja not_active Expired - Fee Related
- 2005-12-01 EP EP05811672A patent/EP1828151B1/fr active Active
- 2005-12-01 RU RU2007120211/04A patent/RU2402538C2/ru not_active IP Right Cessation
- 2005-12-01 PT PT05811672T patent/PT1828151E/pt unknown
- 2005-12-01 DE DE602005027388T patent/DE602005027388D1/de active Active
- 2005-12-01 NZ NZ555184A patent/NZ555184A/en not_active IP Right Cessation
- 2005-12-01 AT AT05811672T patent/ATE504580T1/de active
- 2005-12-01 PL PL05811672T patent/PL1828151T3/pl unknown
- 2005-12-01 MX MX2007006504A patent/MX2007006504A/es active IP Right Grant
- 2005-12-07 AR ARP050105106A patent/AR053987A1/es unknown
- 2005-12-07 TW TW094143269A patent/TWI349005B/zh not_active IP Right Cessation
-
2007
- 2007-05-17 IL IL183293A patent/IL183293A0/en unknown
- 2007-05-24 NO NO20072609A patent/NO20072609L/no not_active Application Discontinuation
- 2007-06-04 ZA ZA200705018A patent/ZA200705018B/xx unknown
-
2008
- 2008-04-29 HK HK08104728.3A patent/HK1114840A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL1828151T3 (pl) | 2011-09-30 |
NO20072609L (no) | 2007-06-19 |
CN101072760A (zh) | 2007-11-14 |
IL183293A0 (en) | 2007-09-20 |
TW200626568A (en) | 2006-08-01 |
AU2005313582B8 (en) | 2011-06-16 |
MX2007006504A (es) | 2007-06-22 |
AR053987A1 (es) | 2007-05-30 |
DE602005027388D1 (de) | 2011-05-19 |
WO2006061136A3 (fr) | 2006-08-03 |
AU2005313582A8 (en) | 2011-06-16 |
RU2007120211A (ru) | 2009-01-20 |
JP4979590B2 (ja) | 2012-07-18 |
PT1828151E (pt) | 2011-06-16 |
EP1828151A2 (fr) | 2007-09-05 |
NZ555184A (en) | 2010-01-29 |
DK1828151T3 (da) | 2011-05-16 |
ATE504580T1 (de) | 2011-04-15 |
US20060122168A1 (en) | 2006-06-08 |
AU2005313582B2 (en) | 2011-06-02 |
JP2008522994A (ja) | 2008-07-03 |
CA2589196A1 (fr) | 2006-06-15 |
KR100890678B1 (ko) | 2009-03-26 |
KR20070086979A (ko) | 2007-08-27 |
TWI349005B (en) | 2011-09-21 |
US7211573B2 (en) | 2007-05-01 |
WO2006061136A2 (fr) | 2006-06-15 |
ZA200705018B (en) | 2010-04-28 |
EP1828151B1 (fr) | 2011-04-06 |
RU2402538C2 (ru) | 2010-10-27 |
BRPI0518615A2 (pt) | 2008-11-25 |
AU2005313582A1 (en) | 2006-06-15 |
CN101072760B (zh) | 2011-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1114840A1 (en) | Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease | |
EP1807396A4 (fr) | Composes de 2-aminopyridine utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer | |
EP1758854A4 (fr) | Composes pyrrolidin-3-yle utiles en tant qu'inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer | |
EP1756040A4 (fr) | Composés de phényl carboxamide utilisables comme inhibiteurs de bêta sécrétase dans le traitement de la maladie d"alzheimer | |
EP1643986A4 (fr) | Inhibiteurs de la beta-secretase de phenylcarboxylate destines au traitement de la maladie d'alzheimer | |
EP1740581A4 (fr) | Composes derives de pyridyle substitues aux positions 2, 4, 6 utiles comme inhibiteurs de la beta-secretase dans le traitement de la maladie d'alzheimer | |
EP1940373B8 (fr) | 1-fluoro-1-deoxy-scyllo-inositol destine au traitement de la maladie d'alzheimer | |
EP1583750A4 (fr) | Inhibiteurs de beta-secretase macrocyclique pour traiter la maladie d'alzheimer | |
CY2015025I2 (el) | Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον | |
EP1740559A4 (fr) | Derives de phenyle 1,3,5-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer | |
EP2063889A4 (fr) | Inhibiteurs de la spiropipéridine bêta-sécrétase pour le traitement de la maladie d'alzheimer | |
EP1641748A4 (fr) | Inhibiteurs de la beta-secretase a base de n-alkyle phenylcarboxamide pour le traitement de la maladie d'alzheimer | |
HK1134923A1 (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
MXPA05008172A (es) | Derivados de malonamida como inhibidores gamma-secretasa. | |
EP1855679A4 (fr) | Inhibiteurs de la beta-secretase d'aminomethyle dans le traitement de la maladie d'alzheimer | |
EP1656359A4 (fr) | Inhibiteurs macrocycliques de la beta-secretase destines au traitement de la maladie d'alzheimer | |
EP1951709A4 (fr) | Composes d imidazolidinone utiles en tant qu inhibiteurs de la beta-secretase lors du traitement de la maladie d alzheimer | |
SI2527315T1 (sl) | Spojine, sestavki in metode za zdravljenje amiloidnih bolezni in sinukleinopatij, kot so Alzheimerjeva bolezen, diabetes tipa 2 in Parkinsonova bolezen | |
EP1817311A4 (fr) | Derives pyridyle 2,3,4,6-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer | |
EP2268647A4 (fr) | Composés et compositions pour la détection et le traitement de la maladie d'alzheimer et des troubles associés | |
EP1814537A4 (fr) | Inhibiteurs de la beta-secretase formes d'amines tertiaires macrocycliques pour le traitement de la maladie d'alzheimer | |
IL172018A0 (en) | Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases | |
GB0521716D0 (en) | Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases | |
PL1631296T3 (pl) | Pochodne amidu kwasu 2,3,4,5,-tetrahydrobenzo[f][1,4]oksazepino-5-karboksylowego jako inhibitory gamma-sekretazy do leczenia choroby Alzheimera | |
IL184849A0 (en) | Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151201 |